TB drug susceptibility testing in high fluoroquinolone resistance settings

BACKGROUND: The insurgence of resistance to key drugs of the BPaLM (bedaquiline + pretomanid + moxifloxacin) regimen is a major concern. In settings with widespread resistance to fluoroquinolones (FQs), like Pakistan, new technologies, such as Xpert® MTB/XDR, may ensure drug resistance upfront scree...

Full description

Saved in:
Bibliographic Details
Main Authors: F. Saluzzo, F. Masood, V. Batignani, F. Di Marco, U. Majeed, A. Ghazal, D.M. Cirillo, S. Tahseen
Format: Article
Language:English
Published: International Union Against Tuberculosis and Lung Disease (The Union) 2024-05-01
Series:IJTLD Open
Subjects:
Online Access:https://www.ingentaconnect.com/contentone/iuatld/ijtldo/2024/00000001/00000005/art00006
Tags: Add Tag
No Tags, Be the first to tag this record!